Clinical Data Financial Statements
Clinical Data Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | March |
© 2009 Morningstar, Inc. Financial Data provided by
Clinical Data Income Statement
| 2009 | 2008 | 2007 | |
|---|---|---|---|
| Revenue ($ mil.) | 10.4 | 34.0 | 63.7 |
| Gross Profit ($ mil.) | 4.0 | 7.8 | 22.8 |
| Operating Income ($ mil.) | (121.9) | (45.6) | (25.9) |
| Total Net Income ($ mil.) | (132.4) | (35.3) | (37.5) |
| Diluted EPS (Net Income) | (6.03) | (1.85) | (2.65) |
Clinical Data Quarterly Statements
| Quarter Ending Jun 09 | Quarter Ending Mar 09 | Quarter Ending Dec 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 3.7 | (17.7) | 10.1 |
| Gross Profit ($ mil.) | 2.0 | (4.0) | 3.2 |
| Operating Income ($ mil.) | -- | (13.9) | (23.2) |
| Total Net Income ($ mil.) | (15.4) | (23.9) | (23.7) |
| Diluted EPS (Net Income) | (0.67) | (1.01) | (1.04) |
Clinical Data Stock Quote & Chart
11/09/09 16:00:00 EST •
NASDAQ •
15.22
•
 -0.0200
•
-0.1312 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Clinical Data Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 28.25 | 7.55 | 7.01 |
| Price/Earnings Ratio | (2.60) | 93.46 | 25.51 |
| Price/Book Ratio | 16.31 | 3.48 | 6.74 |
| Price/Cash Flow Ratio | (5.37) | 41.49 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Clinical Data Financial Ratios
Clinical Data Competitive Intelligence
| Eli Lilly | Illumina | Third Wave Technologies | |
|---|---|---|---|
| Annual Sales ($ mil.) | 20,378.0 | 573.2 | 0.0 |
| Employees | 40,500 | 1,536 | 179 |
| Market Cap ($ mil.) | 39,641.3 | 4,083.0 | -- |
Competitive Landscape
